M&G plc is a prominent savings and investments firm established in 2017 through the merger of Prudential plc’s UK and Europe savings and insurance operations with M&G, its international investment manager. Following its demerger from Prudential plc, M&G plc operates under two key brands: Prudential, serving savings and insurance customers in the UK and Europe, and M&G Investments, which caters to asset management clients globally. The firm manages a diverse range of investment products across various asset classes, including equities, multi-asset, fixed income, real estate, and cash, serving both retail and institutional clients in 28 markets. M&G manages significant private assets, including bank loans, infrastructure, and real estate, while also providing financial planning services through a network of advisers in the UK. With a commitment to delivering tailored investment solutions, M&G plc plays a vital role in helping customers navigate their financial futures.
CEO, Asset Management and Member of Executive Committee
13 past transactions
Udaan
Series G in 2025
Udaan is a B2B e-commerce platform based in India that connects businesses with suppliers across various sectors, including FMCG, pharmaceuticals, and staples. It aims to address core trade challenges faced by small, medium, and large enterprises by providing a centralized platform for buying and selling goods. Udaan facilitates direct connections between clients, allowing them to negotiate better deals while ensuring secure payment processes and efficient logistics. The platform also supports small businesses by offering financial products tailored to their needs, thereby enhancing their operational capabilities and market reach.
SeQura
Venture Round in 2024
SeQura is a Barcelona-based company founded in 2013 that specializes in eCommerce payment solutions designed to enhance conversion rates and ensure secure transactions for retailers. The company provides a variety of payment methods, including immediate payment options and flexible plans such as "Buy Now Pay Later" and installment payments. SeQura's platform incorporates innovative risk scoring to improve credit access for underserved customers, catering to various sectors by offering tailored solutions that enhance customer acquisition, conversion, and retention. By focusing on user-friendly payment experiences, SeQura enables businesses to optimize sales performance while appealing to value-conscious shoppers.
BauMont
Acquisition in 2024
BauMont is a real estate private equity investment firm that offers investment management services.
Nuclera
Series C in 2024
Nuclera is a biotechnology company specializing in an automated protein prototyping system aimed at enhancing drug discovery processes. Its eProtein Discovery system enables researchers to rapidly produce and test high-quality, soluble, and active proteins, significantly accelerating protein projects. By integrating technology such as cell-free protein synthesis and digital microfluidics, Nuclera provides a high-throughput platform for automated protein access. This innovative approach allows scientists to obtain reliable proteins within a short timeframe, facilitating faster progress in their research and contributing to more efficient drug development efforts.
Apollo Therapeutics
Series C in 2024
Apollo Therapeutics is a biopharmaceutical company based in Cambridge, United Kingdom, that collaborates with three leading UK universities—Imperial College London, University College London, and the University of Cambridge—and three major pharmaceutical companies. The company focuses on translating groundbreaking medical research into effective therapeutics, facilitating the development of pre-clinical and clinical-stage assets. Apollo Therapeutics manages a venture capital fund that provides financial and technical support for innovative projects sourced from top British academic research, with a particular emphasis on areas such as oncology, major inflammatory disorders, and rare diseases. By leveraging its experienced team of industry scientists, Apollo aims to optimize therapeutic delivery and enhance patient treatments and outcomes, establishing a strong link between academia and the pharmaceutical industry to foster impactful medical advancements.
Udaan
Series E in 2023
Udaan is a B2B e-commerce platform based in India that connects businesses with suppliers across various sectors, including FMCG, pharmaceuticals, and staples. It aims to address core trade challenges faced by small, medium, and large enterprises by providing a centralized platform for buying and selling goods. Udaan facilitates direct connections between clients, allowing them to negotiate better deals while ensuring secure payment processes and efficient logistics. The platform also supports small businesses by offering financial products tailored to their needs, thereby enhancing their operational capabilities and market reach.
Apollo Therapeutics
Series C in 2023
Apollo Therapeutics is a biopharmaceutical company based in Cambridge, United Kingdom, that collaborates with three leading UK universities—Imperial College London, University College London, and the University of Cambridge—and three major pharmaceutical companies. The company focuses on translating groundbreaking medical research into effective therapeutics, facilitating the development of pre-clinical and clinical-stage assets. Apollo Therapeutics manages a venture capital fund that provides financial and technical support for innovative projects sourced from top British academic research, with a particular emphasis on areas such as oncology, major inflammatory disorders, and rare diseases. By leveraging its experienced team of industry scientists, Apollo aims to optimize therapeutic delivery and enhance patient treatments and outcomes, establishing a strong link between academia and the pharmaceutical industry to foster impactful medical advancements.
Bluejay Mining
Post in 2023
Bluejay Mining is a mining company focused on the exploration and development of precious and base metals, including copper, nickel, zinc, gold, lead, titanium, silver, and platinum group metals. The company operates primarily in Greenland, Finland, and the United Kingdom, with its flagship project being the Dundas Ilmenite Project in Greenland, recognized as the highest-grade mineral sand ilmenite project globally. The Dundas project is notable for its world-class quality resource and significant expansion potential, having only a fraction of its raised beach area assessed. Additionally, Bluejay Mining is involved in other projects such as Kangerluarsuk, Disko-Nuussuaq, and Thunderstone. Established in 2005 and headquartered in London, the company was formerly known as FinnAust Mining Plc before rebranding in March 2017.
Teylor
Debt Financing in 2023
Teylor AG, founded in 2018 and based in Zurich, Switzerland, with an additional location in Konstanz, Germany, specializes in providing loans to small and medium-sized enterprises (SMEs). The company has developed an efficient online lending platform that streamlines the credit application and underwriting process, allowing applicants to receive a credit offer in under ten minutes and access loans of up to €250,000 within two days. Users can complete the entire process directly on Teylor's website by filling out a simple form, after which Teylor analyzes various data points to generate an offer quickly. Teylor also partners with manufacturers, brokers, and financial advisors to extend its loan offerings to their clients. In the long term, Teylor aims to license its innovative processes and technologies to financial institutions, enabling banks to automate and enhance their SME lending operations while reducing costs associated with underwriting and administration.
eTherapeutics
Post in 2022
eTherapeutics is a drug discovery and development company based in the UK. It focuses on transforming the drug discovery process by utilizing its proprietary computational network biology platform. This advanced system enables the swift and accurate analysis of drug interactions with cells, aiming to identify novel targets that address the mechanisms underlying complex diseases. By optimizing the identification of drug candidates with desirable efficacy and minimal side effects, eTherapeutics seeks to enhance the drug development process and contribute to the advancement of medical treatments.
Finance Ireland
Secondary Market in 2022
Finance Ireland is a non-bank lender that focuses on providing a variety of financing solutions across several sectors, including agriculture, construction, healthcare, dental, and retail. As Ireland's largest independent motor finance company, it facilitates the purchase of vehicles for over 25,000 car buyers annually. In addition to motor finance, Finance Ireland offers comprehensive lending options for small and medium enterprises (SMEs) and the agricultural sector, covering investments in vehicles, machinery, plants, and equipment. The company aims to provide an alternative to traditional banking, offering both residential and commercial mortgages as part of its diverse financial services. With a dedicated team of lending managers, Finance Ireland assists investors throughout the funding process.
Ascentric
Acquisition in 2020
Ascentric is a digital wrap and wealth management platform for advisers with assets under administration.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.